Host Susceptibility or Environmental Exposure in Mycobacterium avium Complex Lung Disease It Takes Two to Tango

被引:5
|
作者
Marras, Theodore K. [1 ,2 ,3 ]
机构
[1] Univ Hlth Network, Dept Med, Toronto, ON, Canada
[2] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada
[3] Univ Toronto, Dept Med, Toronto, ON, Canada
关键词
RISK-FACTORS; NONTUBERCULOUS MYCOBACTERIA; PULMONARY-DISEASE; INFECTION; INTRACELLULARE; PREVALENCE; ONTARIO;
D O I
10.1164/rccm.201208-1432ED
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:585 / 586
页数:2
相关论文
共 50 条
  • [21] NLRP3 inflammasome is attenuated in patients with Mycobacterium avium complex lung disease and correlated with decreased interleukin-1β response and host susceptibility
    Wu, Ming-Fang
    Shu, Chin-Chung
    Wang, Jann-Yuan
    Yan, Bo-Shiun
    Lai, Hsin-Chih
    Chiang, Bor-Luen
    Wu, Lawrence Shih-Hsin
    Yu, Chong-Jen
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [22] NLRP3 inflammasome is attenuated in patients with Mycobacterium avium complex lung disease and correlated with decreased interleukin-1β response and host susceptibility
    Ming-Fang Wu
    Chin-Chung Shu
    Jann-Yuan Wang
    Bo-Shiun Yan
    Hsin-Chih Lai
    Bor-Luen Chiang
    Lawrence Shih-Hsin Wu
    Chong-Jen Yu
    Scientific Reports, 9
  • [23] NLRP3 Inflammasome Is Attenuated in Patients with Mycobacterium Avium Complex Lung Disease and Correlated with Decreased Il-1β Response and Host Susceptibility
    Shu, C.
    Wu, M.
    Yu, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [24] Giant lamellar bodies in a case of Mycobacterium avium complex lung disease
    Sun, AP
    Ohtsuki, Y
    Fujita, J
    Shigeto, E
    Kohno, N
    PATHOLOGY, 2002, 34 (05) : 473 - 475
  • [25] Factors Associated with Frailty in Patients with Mycobacterium Avium Complex Lung Disease
    Fujita, K.
    Ito, Y.
    Uchida, N.
    Yamamoto, Y.
    Kanai, O.
    Okamura, M.
    Nakatani, K.
    Mio, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [26] Therapeutic outcomes for cavitary Mycobacterium avium complex (MAC) lung disease
    Griffith, David
    Brown-Elliott, Barbara
    Shepherd, Sara
    Philley, Julie
    Wallace, Richard
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [27] Clarithromycin treatment for Mycobacterium avium-intracellulare complex lung disease
    Wallace, RJ
    Griffith, DE
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 153 (06) : 1990 - 1991
  • [28] Development of a prognostic scoring system for Mycobacterium avium complex lung disease
    Kumagai, Shogo
    Ito, Akihiro
    Furuuchi, Koji
    Ishida, Tadashi
    Hashimoto, Toru
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [29] Cavitary Mycobacterium avium Complex Lung Disease Developed After Immunotherapy
    Chi, Chien-Yeh
    Yeh, Yi-Chen
    Pan, Sheng-Wei
    ARCHIVOS DE BRONCONEUMOLOGIA, 2022, 58 (02): : 174 - 174
  • [30] Outcomes of Mycobacterium avium complex lung disease based on clinical phenotype
    Koh, Won-Jung
    Moon, Seong Mi
    Kim, Su-Young
    Woo, Min-Ah
    Kim, Seonwoo
    Jhun, Byung Woo
    Park, Hye Yun
    Jeon, Kyeongman
    Huh, Hee Jae
    Ki, Chang-Seok
    Lee, Nam Yong
    Chung, Myung Jin
    Lee, Kyung Soo
    Shin, Sung Jae
    Daley, Charles L.
    Kim, Hojoong
    Kwon, O. Jung
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50 (03)